Promega Corporation

Technically Speaking: Anti-ACTIVE™ Antibodies to MAPK JNK and p38

Share

  • Share
  • Print
  • Email
  • Download PDF

Abstract

Promega has combined state-of-the-art phosphopeptide synthesis, antibody production and purification strategies to generate three highly selective antibodies raised against the active form of key enzymes of the ERK/MAP kinase superfamily. These rabbit polyclonal Anti-ACTIVE™ Antibodies are specific to the active, dually phosphorylated forms of these enzymes and can be used to detect active enzyme by a variety of methods.

Promega Notes 64, 31.

Doug Barron

Promega Corporation
Publication Date: 1997

Download Article (162 KB)

It appears that you have Javascript disabled. Our website requires Javascript to function correctly. For the best browsing experience, please enable Javascript.

Scientists at Your Service

Scientists at Your Service

We offer a range of services to help you succeed using Promega technologies. From product training to set up of automated systems and development of custom applications—our scientific support goes beyond the basics.

Ask us! We are here to help you.